{"id":"https://openalex.org/W2807549853","doi":"https://doi.org/10.1371/journal.pone.0197372","title":"Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation","display_name":"Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2807549853","doi":"https://doi.org/10.1371/journal.pone.0197372","mag":"2807549853","pmid":"https://pubmed.ncbi.nlm.nih.gov/29856759","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5983452"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0197372","doi":"https://doi.org/10.1371/journal.pone.0197372","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197372","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197372&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197372&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046769048","display_name":"Michael J. Thomenius","orcid":"https://orcid.org/0000-0002-3357-7872","observed_orcids":["https://orcid.org/0000-0002-3357-7872"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael J. Thomenius","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":"https://orcid.org/0000-0002-3357-7872","affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039768054","display_name":"Jennifer Totman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Totman","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038142765","display_name":"Darren M. Harvey","orcid":"https://orcid.org/0009-0005-5561-3749","observed_orcids":["https://orcid.org/0009-0005-5561-3749"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darren Harvey","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111383249","display_name":"Lorna H. Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorna H. Mitchell","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032612285","display_name":"Thomas V. Riera","orcid":"https://orcid.org/0000-0001-7427-2728","observed_orcids":["https://orcid.org/0000-0001-7427-2728"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas V. Riera","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030364793","display_name":"Kat Cosmopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kat Cosmopoulos","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000162907","display_name":"Alexandra R. Grassian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra R. Grassian","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081590980","display_name":"Christine R. Klaus","orcid":"https://orcid.org/0000-0002-5880-6870","observed_orcids":["https://orcid.org/0000-0002-5880-6870"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Klaus","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Megan Foley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Foley","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061746622","display_name":"Elizabeth A. Admirand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Admirand","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110044367","display_name":"Haris Jahi\u0107","orcid":"https://orcid.org/0009-0005-3755-8889","observed_orcids":["https://orcid.org/0009-0005-3755-8889"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haris Jahic","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064617551","display_name":"Christina R. Majer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Majer","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041910319","display_name":"Tim J. Wigle","orcid":"https://orcid.org/0000-0002-7010-6738","observed_orcids":["https://orcid.org/0000-0002-7010-6738"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim Wigle","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112470529","display_name":"Suzanne L. Jacques","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne L. Jacques","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028760433","display_name":"Jodi Gureasko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi Gureasko","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033498009","display_name":"Dorothy Brach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorothy Brach","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058973099","display_name":"Trupti Lingaraj","orcid":"https://orcid.org/0009-0004-9509-3437","observed_orcids":["https://orcid.org/0009-0004-9509-3437"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trupti Lingaraj","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046123085","display_name":"Kip A. West","orcid":"https://orcid.org/0000-0002-3891-0830","observed_orcids":["https://orcid.org/0000-0002-3891-0830"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kip West","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042465529","display_name":"Sherri A. Smith","orcid":"https://orcid.org/0000-0002-9744-3208","observed_orcids":["https://orcid.org/0000-0002-9744-3208"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherri Smith","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020307922","display_name":"Nathalie Rioux","orcid":"https://orcid.org/0000-0003-2995-1734","observed_orcids":["https://orcid.org/0000-0003-2995-1734"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Rioux","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002606637","display_name":"Nigel J. Waters","orcid":"https://orcid.org/0000-0002-5063-295X","observed_orcids":["https://orcid.org/0000-0002-5063-295X"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nigel J. Waters","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109995247","display_name":"Cuyue Tang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cuyue Tang","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079181273","display_name":"Alejandra Raimondi","orcid":"https://orcid.org/0009-0009-2497-8402","observed_orcids":["https://orcid.org/0009-0009-2497-8402"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandra Raimondi","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088309950","display_name":"Michael J. Munchhof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Munchhof","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061496931","display_name":"James E. J. Mills","orcid":"https://orcid.org/0000-0002-2567-3872","observed_orcids":["https://orcid.org/0000-0002-2567-3872"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James E. Mills","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055002979","display_name":"Scott A. Ribich","orcid":"https://orcid.org/0009-0004-2325-8036","observed_orcids":["https://orcid.org/0009-0004-2325-8036"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Ribich","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022609500","display_name":"Margaret Porter Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Porter Scott","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041960498","display_name":"Kevin W. Kuntz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin W. Kuntz","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022896009","display_name":"William P. Janzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William P. Janzen","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111682318","display_name":"Mikel P. Moyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikel Moyer","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060751046","display_name":"Jesse Joshua Smith","orcid":"https://orcid.org/0000-0003-2538-5456","observed_orcids":["https://orcid.org/0000-0003-2538-5456"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse J. Smith","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015187022","display_name":"Richard Chesworth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Chesworth","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103131022","display_name":"Robert A. Copeland","orcid":"https://orcid.org/0000-0003-2606-2288","observed_orcids":["https://orcid.org/0000-0003-2606-2288"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Copeland","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052339827","display_name":"P. Ann Boriack\u2010Sjodin","orcid":"https://orcid.org/0000-0003-0179-5936","observed_orcids":["https://orcid.org/0000-0003-0179-5936"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Ann Boriack-Sjodin","raw_affiliation_strings":["Epizyme, Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5046769048"],"corresponding_institution_ids":["https://openalex.org/I4210109703"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":2.8877,"has_fulltext":true,"cited_by_count":62,"citation_normalized_percentile":{"value":0.92693442,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"13","issue":"6","first_page":"e0197372","last_page":"e0197372"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smyd2","display_name":"SMYD2","score":1.0},{"id":"https://openalex.org/keywords/smyd3","display_name":"SMYD3","score":1.0},{"id":"https://openalex.org/keywords/protein-lysine-methyltransferase","display_name":"lysine methyltransferase","score":0.9520000219345093},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/crispr-cas9-mutagenesis","display_name":"CRISPR/Cas9 mutagenesis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/chemical-probes","display_name":"chemical probes","score":0.6890000104904175},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.8526955842971802},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.7088183760643005},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6544497013092041},{"id":"https://openalex.org/C16318435","wikidata":"https://www.wikidata.org/wiki/Q149299","display_name":"Mutagenesis","level":4,"score":0.6291519999504089},{"id":"https://openalex.org/C132455925","wikidata":"https://www.wikidata.org/wiki/Q16965677","display_name":"Cas9","level":4,"score":0.6246092915534973},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5933763980865479},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.5300851464271545},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.4769762456417084},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4196528196334839},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.32379820942878723},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.31112736463546753},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3002903163433075},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000072283","descriptor_name":"A549 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008745","descriptor_name":"Methylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008780","descriptor_name":"Methyltransferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011495","descriptor_name":"Histone-Lysine N-Methyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011495","descriptor_name":"Histone-Lysine N-Methyltransferase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011495","descriptor_name":"Histone-Lysine N-Methyltransferase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D063646","descriptor_name":"Carcinogenesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D063646","descriptor_name":"Carcinogenesis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D064113","descriptor_name":"CRISPR-Cas Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0197372","doi":"https://doi.org/10.1371/journal.pone.0197372","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197372","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197372&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4954648","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5983452","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5983452","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5983452","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:29856759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29856759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:osti.gov:1545851","doi":null,"is_oa":true,"landing_page_url":"https://www.osti.gov/biblio/1545851","pdf_url":"https://www.osti.gov/servlets/purl/1545851","source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"pmh:oai:doaj.org/article:8d24a066e3c44272bf8a8c8842bb3428","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8d24a066e3c44272bf8a8c8842bb3428","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 13, Iss 6, p e0197372 (2018)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/6404159","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Small_molecule_inhibitors_and_CRISPR_Cas9_mutagenesis_demonstrate_that_SMYD2_and_SMYD3_activity_are_dispensable_for_autonomous_cancer_cell_proliferation/6404159","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0197372","doi":"https://doi.org/10.1371/journal.pone.0197372","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197372","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197372&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.766700029373169,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2807549853.pdf","grobid_xml":"https://content.openalex.org/works/W2807549853.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1492849291","https://openalex.org/W1847375317","https://openalex.org/W1982186851","https://openalex.org/W1982682419","https://openalex.org/W1987777080","https://openalex.org/W1988323955","https://openalex.org/W1996097026","https://openalex.org/W1997403578","https://openalex.org/W2005784985","https://openalex.org/W2017492512","https://openalex.org/W2022498921","https://openalex.org/W2031930309","https://openalex.org/W2036079358","https://openalex.org/W2038840577","https://openalex.org/W2039802417","https://openalex.org/W2042333098","https://openalex.org/W2042811126","https://openalex.org/W2047153191","https://openalex.org/W2049828484","https://openalex.org/W2050158252","https://openalex.org/W2050877272","https://openalex.org/W2051406272","https://openalex.org/W2054576391","https://openalex.org/W2065215000","https://openalex.org/W2067833766","https://openalex.org/W2071407989","https://openalex.org/W2074631079","https://openalex.org/W2093120703","https://openalex.org/W2101892858","https://openalex.org/W2103503400","https://openalex.org/W2108921801","https://openalex.org/W2114367386","https://openalex.org/W2124026197","https://openalex.org/W2136996386","https://openalex.org/W2146634563","https://openalex.org/W2166594615","https://openalex.org/W2169840774","https://openalex.org/W2255206707","https://openalex.org/W2284685321","https://openalex.org/W2287573955","https://openalex.org/W2301007008","https://openalex.org/W2309996550","https://openalex.org/W2314949394","https://openalex.org/W2337020460","https://openalex.org/W2520034413","https://openalex.org/W2601913258","https://openalex.org/W2603189030","https://openalex.org/W2770279769","https://openalex.org/W2788248099"],"related_works":["https://openalex.org/W2937213302","https://openalex.org/W1847375317","https://openalex.org/W7081951216","https://openalex.org/W3112509679","https://openalex.org/W2589002426","https://openalex.org/W3200865149","https://openalex.org/W1982682419","https://openalex.org/W4289338322","https://openalex.org/W2390815262","https://openalex.org/W2564246177"],"abstract_inverted_index":{"A":[0],"key":[1],"challenge":[2],"in":[3],"the":[4,11,45,48,55,78,85,89,110],"development":[5],"of":[6,14,17,27,37,47,73,77,81,84,88,109],"precision":[7],"medicine":[8],"is":[9,50],"defining":[10],"phenotypic":[12],"consequences":[13],"pharmacological":[15],"modulation":[16],"specific":[18],"target":[19],"macromolecules.":[20],"To":[21],"address":[22],"this":[23,62],"issue,":[24],"a":[25],"variety":[26],"genetic,":[28],"molecular":[29],"and":[30,54,94,117,126],"chemical":[31,130],"tools":[32,49],"can":[33,40],"be":[34],"used.":[35],"All":[36],"these":[38,66],"approaches":[39,125],"produce":[41],"misleading":[42],"results":[43],"if":[44],"specificity":[46],"not":[51,59],"well":[52,102],"understood":[53],"proper":[56],"controls":[57],"are":[58],"performed.":[60],"In":[61],"paper":[63],"we":[64],"illustrate":[65],"general":[67],"themes":[68],"by":[69],"providing":[70],"detailed":[71],"studies":[72],"small":[74],"molecule":[75],"inhibitors":[76],"enzymatic":[79],"activity":[80],"two":[82],"members":[83],"SMYD":[86],"branch":[87],"protein":[90],"lysine":[91],"methyltransferases,":[92],"SMYD2":[93,116],"SMYD3.":[95],"We":[96],"show":[97],"that":[98],"tool":[99],"compounds":[100],"as":[101,103],"CRISPR/Cas9":[104],"fail":[105],"to":[106],"reproduce":[107],"many":[108],"cell":[111],"proliferation":[112],"findings":[113],"associated":[114],"with":[115,122,127],"SMYD3":[118],"inhibition":[119],"previously":[120],"obtained":[121],"RNAi":[123],"based":[124],"early":[128],"stage":[129],"probes.":[131]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-06-13T00:00:00"}